1. HOME
2. Research Insight
3. Bio-Rad Laboratories, Inc. (US) and Thermo Fisher Scientific Inc. (US) are Leading Players in the Electrophoresis Market

The global electrophoresis market is expected to reach USD 4.1 billion by 2028 from USD 3.1 billion in 2023, at a CAGR of 5.7% during the forecast period.

Factors such as the growing number of industrial collaborations for research, increasing use of capillary electrophoresis and  use of next-generation sequencing technique. For Instance, Thermo Fisher Scientific Inc.  (US) have recently introduced a new Applied Biosystems SeqStudio Flex Series Genetic Analyzer based on capillary electrophoresis technology to enable customers’ cutting-edge research in areas such as gene editing and infectious disease and QIAGEN N.V. (Netherlands) and Helix (US) entered into a partnership agreement for the development of next-generation sequencing companion diagnostics in hereditary diseases

To know about the assumptions considered for the study download the pdf brochure

The electrophoresis market is highly consolidated and is dominated by various players. The major players operating in this market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US). activities further act launches, contracts, partnerships, mergers and acquisitions, and new product development activities further to expand their presence in the electrophoresis market.

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories is a leading player in both the gel and capillary electrophoresis markets, with a wide portfolio of systems as well as consumables. The company also offers electrophoretic software solutions to customers and analytical services. The company has a significant presence in more than 35 countries, which maintains its global market position. In the last three years, the firm opened life science centers in China, India, South Korea, and Singapore to facilitate the supply of its products. Bio-Rad has emphasized targeted acquisitions to complement its strengths. The company has also invested a significant amount of its revenue in R&D in bringing innovative products to this market space. In this regard, the company invested about USD 0.26 billion in R&D in 2022.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific is a leading player of the electrophoresis market in 2022. The company invested USD 1.47 Billion in R&D activities in 2022. A significant focus on R&D activities helps the company provide innovative products and maintain and improve its competitive position in the electrophoresis market. Thermo Fisher Scientific Inc. serves more than 400,000 customers in different pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies, as well as the environment sector. With its broad product portfolio, acquisitions,  new product launches, and wide geographic presence as the company operates in more than 180 countries across North America, Europe, Asia, the Middle East, Africa, and Latin America. The company introduced a new Applied Biosystems SeqStudio Flex Series Genetic Analyzer to enable customers’ cutting-edge research in areas such as gene editing and infectious disease and The company acquired PeproTech, Inc., a leading developer and manufacturer of recombinant proteins, to provide customers with significant benefits through an integrated offering. The company is expected to grow at a high rate in the electrophoresis  market during the forecast period.

Danaher Corporation

Danaher Corporation is an important player in the electrophoresis market. Danaher focuses on improving its business performance by enhancing its portfolio for critical areas of quality, delivery, cost, growth, and innovation. The company has a strong presence across 50 countries spanning North America, Europe, and the Asia Pacific. In these geographies, it operates through its subsidiaries that are focused on R&D, manufacturing, sales, distribution, and services. For instance, Recently the company launched RNA 9000 Purity & Integrity kit for the BioPhase 8800 system and PA 800 Plus system and The company acquired GE Healthcare Life Sciences Biopharma and rebranded it as Cytiva. This company is a USD 3.3-billion global life sciences company with nearly 7000 employees in 40 countries.  In 2022, the company spent USD 1.75 Billion on R&D. Furthermore, research and development increased nearly 30%, allowing us to deliver breakthrough innovation more quickly. It is focused on opportunities to extend its global reach and advance its technology.

MERCK KGAA

Merck KgaA has a well-established geographic presence and a well-recognized brand name globally. The company provides more than 60,000 products across 66 countries. Merck Millipore’s major sites include Bedford (US), Jaffrey (US), Darmstadt (Germany), Molsheim (France), Beijing (China), and Bangalore (India). The company operates in the US, Europe, the Asia Pacific, the Middle East, and Africa. It is present in more than 120 countries globally. Some of its major subsidiaries are Merck Millipore (US), EMD Pharmaceuticals Inc. (US), and Sigma-Aldrich Corporation (US). The company has taken various initiatives to maintain its leadership and share in the global electrophoresis market. The company invested heavily in its R&D activities—USD 2.69 billion in 2022.

Agilent Technologies, Inc.

Agilent, with its extensive product range, is a leading provider in the electrophoresis market. With a presence across more than 100 countries, Agilent provides various automated and capillary electrophoresis systems for both protein and nucleic acid analysis. Its high R&D expenditure assists in product development, thereby strengthening the company’s product portfolio. In 2022, the company spent USD 0.47 Billion on R&D. The company can increase its focus on countries such as Brazil, Mexico, New Zealand, the Middle East, East Asia, and Russia, as they showcase an enormous growth potential in the electrophoresis market. Moreover, the company acquires smaller players to enhance its market position and acquire or bolster its capabilities in new fields. For Instance, CMP Scientific Corp announced that it had signed a global co-marketing agreement with Agilent Technologies to provide an integrated CE-MS solution to the life science and pharmaceutical industry.

Related Reports:

Electrophoresis Market by Product (Reagents (Protein & Nucleic Acid), (Gel Electrophoresis (1D & 2D), Capillary Electrophoresis (CZE, CGE), GDS, Software), Application (Research, Diagnostics), End User (Hospitals) & Region - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]